Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

Aspartylglucosaminuria

MONDO:0008830

Aspartylglycosaminuria (AGU) is an autosomal recessive lysosomal storage disease belonging to the oligosaccharidosis group (also called glycoproteinosis).

Also known as: Aspartylglycosaminuria, aspartylglucosaminidase deficiency, aspartylglucosaminuria, aspartylglycosaminuria, glycosylasparaginase deficiency, AGU, Aga deficiency, Aspartylglucosamidase (AGA) deficiency

4 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (680) Metabolic disease (233) Musculoskeletal system disorder (207) Hereditary disease (176) Bone disorder (51) Inborn errors of metabolism (45) Lysosomal storage disease (35) Human disease (14) Developmental defect during embryogenesis (8) Skeletal system disorder (4)
Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2
Sort by
  • Nanoparticles boost radiation against tough brain tumors

    Disease control Recruiting now

    This study tests whether adding AGuIX gadolinium-based nanoparticles to standard brain radiation can better control brain metastases that are at high risk of coming back. About 134 adults with certain cancers (like melanoma, lung, breast, or colorectal) that have spread to the br…

    Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control

    Last updated Jun 27, 2026 14:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space